Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-01-30
1999-09-21
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 18, 530329, 530330, 530331, A61K 3804, A61K 3805, A61K 3808
Patent
active
059554312
ABSTRACT:
Compositions and methods for inhibiting a complex containing a mast cell protease are provided. The compositions are useful for treating inflammatory disorders, such as asthma, that are mediated by release of a tryptase-6 protein. Methods for identifying additional specific inhibitors of a complex containing tryptase-6 protein and a serglycin glycosaminoglycan also are provided.
REFERENCES:
patent: 5087564 (1992-02-01), Mai et al.
patent: 5187157 (1993-02-01), Kettner et al.
patent: 5202239 (1993-04-01), Tarnowski et al.
patent: 5239058 (1993-08-01), Vlasuk et al.
patent: 5372812 (1994-12-01), Reed et al.
patent: 5385732 (1995-01-01), Anderson et al.
patent: 5405771 (1995-04-01), Anderson et al.
patent: 5464820 (1995-11-01), Burton
patent: 5525623 (1996-06-01), Spear et al.
patent: 5538863 (1996-07-01), Price
patent: 5541087 (1996-07-01), Lo et al.
patent: 5567602 (1996-10-01), Clark et al.
Ghildval, N., et al., "Fate of Two Mast Cell Tryptases in V3 Mastocytosis and Normal BALB/c Mice Undergoing Passive Systemic Anaphylaxis: Prolonged Retention of Exocytosed mMCP-6 in Connective Tissues, and Rapid Accumulation of Enzymatically Active mMCP-7 in the Blood", J. Exp. Med., (1996), 184:1061-1073.
Matsumoto, R., et al., "Packaging of Proteases and Proteogylcans in the Granules of Mast Cells and Other Hematopoietic Cells", J Biol. Chem., (1995), 270:33:19524-19531.
Braganza, V., et al., "Tryptase from Rat Skin: Pruification and Proerties", Biochemistry, (1991), 30:20:4997-5007.
Clark, J., et al., "Tryptase Inhibitors Block Allergen-induced Airway and Inflammatory Responses in Allergic Sheep", Am J Respir Crit Care Med, (1995), 152:2076-2083.
Gruber, B., et al., "The Mast Cell as an Effector of Connective Tissue Degradation: A Study of Matrix Susceptibility to Human Mast Cells",Biochem & Biophys Res Com, (1990), 171:3:1272-1278.
Cairns, J., et al., "Mast Cell Tryptase Is a Mitogen for Epithelial Cells",J Immun, (1996), 156:275-283.
Kielty, C., et al., "Catabolism of Intact Type VI Collagen Microfibrils: Susceptibility To Degradation By Serine Proteinases", Biochem & Biophys Res Com, (1993), 191:3:1230-1236.
Kovanen, P., et al., "Infiltrates of Activated Mast Cells at the Site of Coronary Atheromatous Erosion or Rupture in Myocardial Infarction", Circulation, (1995), 92:5:1084-1088.
Saarinen, J., et al., "Activation of Human Interstitial Procollagenase through Direct Cleavage of the Leu.sup.83 -Thr.sup.84 Bond by Mast Cell Chymase",J Bio Chem, (1994), 269:27:18134-18140.
DuBuske, L., et al., "Granule-Associated Serine Neutral Proteases of the Mouse Bone Marrow-Derived Mast Cell That Degrade Fibronectin: Their Increases After Sodium Butyrate Treatment of the Cells", J Immun,, (1984), 133:3:1535-1541.
Constantinides, P., et al., "Infiltrates of Activated Mast Cells at the Site of Coronary Atheromatous Erosion or Rupture in Myocardial Infaction", Circulation,(1995), 92:1083.
Leighton et al. FEBS Lett. 375(3), 289-93, Mar. 1995.
Zhi-mei Wang, et al., "Production of Active Recombinant Human Chymase from a Construct Containing the Enterokinase Cleavage Site of Trypsinogen in Place of the Native Propeptide Sequence," Biol. Chem. Hoppe-Seyler, (1995), vol. 376, pp. 681-684.
Bajusz, S., Peptide Inhibitors of Trypsin-Like Enzymes, Symposia Biologica Hungarica 25; pp. 279-298, (1984).
Jouko Lohi et al., Pericellular Substrates of Human Mast Cell Tryptase: 72,000 Dalton Gelatinase and Fibronectin, Journal of Cellular Biochem., 50:337-349 (1992).
Beat Steiner et al., Peptides Derived from a Sequence within .beta..sub.2 Integrin Bind to Platelet .alpha..sub.IIb .beta..sub.-- (GPIIIb-IIIa) and Inhibit Ligand Binding, J. of Biological Chem. 268, No. 10, Apr. 5, 1993, pp. 6870-6873.
Rami Herskoviz et al., Nonpeptidic Analogues of the Arg-Gly-Asp (RGD) Sequence Specifically Inhibit the Adhesion of Human Tenon's Capsule Fibroblasts to Fibronectin, Investigative Opthalmology & Visual Science, vol. 35, No. 5, Apr. 1994, pp. 2585-2591.
McNeil, H.P., et al., Isolation, characterizatin, and transcription of the gene encoding mouse mast cell protease 7, Dec. 1992, vol. 89, pp. 11174-11178.
Schwartz, L., et al., "Effect of Tryptase . . . ", J Allergy Clin Immunol, (1985), 75 (1 Part 2) Abstract.
Ryan, T., et al., "Urticaria and fibrinolysis", Clin Exp Dermatol, (1977), 2:2:177-182 Abstract.
Forsberg, G., et al., "An evaluation of . . . ", J Protein Chem, (1992), 11:2:201-211 Abstract.
Light, A., et al., "The amino-terminal . . . ", J. Protien Chem, (1991), 10:5:475-480 Abstract.
Martinez, A., et al., "Expression of recombinant . . . ", Biochem J., (1995), 306(Pt 2): 589-597 Abstract.
Su, X., et al., "Production of recombinant . . . ", Biotechniques, (1992), 12:5:756-762 Abstract.
Kuhn, S., et al., "The baculovirus expression . . . ", Gene, (1995), 162:2:225-229 Abstract.
Kroll, D., et al., "A multifunctional prokaryotic . . . ", DNA Cell Biol, 12:5:441-453 Abstract.
Dobrynin, V., et al., "Chemical-enzymatic . . . ", Bioorg Khim, (1989), 15:9:1232-1238 Abstract.
Scheele, G., et al., "Proteolytic processing . . . ", J Biol Chem, (1983), 258:3:2005-2009 Abstract.
Huang Chifu
Stevens Richard L.
Borin Michael
Brigham and Women's Hospital, Inc.
Tsang Cecilia J.
LandOfFree
Mast cell protease peptide inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mast cell protease peptide inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mast cell protease peptide inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-80260